Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Risperidone (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone measurement |
Component |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone poisoning |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental risperidone poisoning |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Intentional risperidone poisoning |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la rispéridone d'intention indéterminée |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone adverse reaction |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to risperidone |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone overdose (disorder) |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Accidental risperidone overdose |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional risperidone overdose |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
surdose de rispéridone d'intention indéterminée |
Causative agent (attribute) |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 1mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone depot 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone depot 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone depot 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperdal consta |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperdal consta 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperdal consta 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperdal consta 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing risperidone in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 1mg oro-dispersible tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 2 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 0.25mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 25mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 37.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 50mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 500 microgram orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Accidental risperidone poisoning |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Intentional risperidone poisoning |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 12.5mg powder+solvent for suspension for injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 4 mg orodispersible tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to risperidone |
Causative agent (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 1mg tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 1mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 3 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 500 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 500 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 1mg tablet (substance) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 2 mg oral tablet |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 3 mg oral tablet |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 4 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 6 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 500 microgram oral tablet |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 250 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 12.5 mg powder for suspension for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Risperidone 50 mg powder for suspension for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only risperidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 2 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 2 mg orodispersible tablet |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 3 milligram/1 each conventional release orodispersible tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 500 microgram orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 500 microgram orodispersible tablet |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 4 mg orodispersible tablet |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 4 mg orodispersible tablet |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 1mg oro-dispersible tablet (product) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 1mg oro-dispersible tablet (product) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 12.5 mg powder for suspension for injection vial |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 12.5 mg powder for suspension for injection vial |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 50 mg powder for suspension for injection vial |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 50 mg powder for suspension for injection vial |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing risperidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only risperidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 25 mg powder for prolonged-release suspension for injection vial |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 25 mg powder for prolonged-release suspension for injection vial |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely risperidone 37.5 milligram/1 vial powder for prolonged-release suspension for injection (clinical drug) |
Has basis of strength substance (attribute) |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Risperidone 50 mg powder for prolonged-release suspension for injection vial |
Has precise active ingredient |
True |
Risperidone (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |